Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis

Identifying noninvasive markers of pulmonary inflammation would be useful in assessing new therapies in children. Breath condensate is a simple and potentially acceptable sample medium even in small children. The technique has previously been used in adults, but not children with cystic fibrosis. The technique was assessed in 36 children with cystic fibrosis (mean age 10.4 yrs) and 17 control subjects, analysing samples for nitrite, interleukin(IL)-8 and salivary and nasal contamination. Correlations were made between levels of the inflammatory markers and forced expiratory volume in one second/forced vital capacity, chest radiograph score and use of inhaled steroids. On samples without significant contamination (<10 u x L(-1) amylase) nitrite was detected in 93% of samples at a median concentration of 3.0 microM compared with 50% of control samples at a median of 0.5 microM. Condensate amylase levels did not correlate with the nitrite value obtained (r=0.31). IL-8 was detected in 33% of CF samples. Breath condensate is an acceptable method of sample collection in children. Nitrite was raised in breath condensate from patients with cystic fibrosis when compared with control subjects.

This article has been cited by other articles:

				P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 5 - 23. [Abstract] [PDF]

				S. D. Sagel, J. F. Chmiel, and M. W. Konstan Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease Proceedings of the ATS, August 1, 2007; 4(4): 406 - 417. [Abstract] [Full Text] [PDF]

				J.-L. Corhay, L. Hemelaers, M. Henket, J. Sele, and R. Louis Granulocyte Chemotactic Activity in Exhaled Breath Condensate of Healthy Subjects and Patients With COPD Chest, June 1, 2007; 131(6): 1672 - 1677. [Abstract] [Full Text] [PDF]

				I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]

				H Marteus, D C Tornberg, E Weitzberg, U Schedin, and K Alving Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation Thorax, March 1, 2005; 60(3): 219 - 225. [Abstract] [Full Text] [PDF]

				G. E. Carpagnano, P. J. Barnes, J. Francis, N. Wilson, A. Bush, and S. A. Kharitonov Breath Condensate pH in Children With Cystic Fibrosis and Asthma: A New Noninvasive Marker of Airway Inflammation? Chest, June 1, 2004; 125(6): 2005 - 2010. [Abstract] [Full Text] [PDF]

				E Baraldi, L Ghiro, V Piovan, S Carraro, F Zacchello, and S Zanconato Safety and success of exhaled breath condensate collection in asthma Arch. Dis. Child., April 1, 2003; 88(4): 358 - 360. [Abstract] [Full Text] [PDF]

				W. Formanek, D. Inci, R.P. Lauener, J.H. Wildhaber, U. Frey, and G.L. Hall Elevated nitrite in breath condensates of children with respiratory disease Eur. Respir. J., March 1, 2002; 19(3): 487 - 491. [Abstract] [Full Text] [PDF]

				V. De Rose Mechanisms and markers of airway inflammation in cystic fibrosis Eur. Respir. J., February 1, 2002; 19(2): 333 - 340. [Abstract] [Full Text] [PDF]

				G. M. MUTLU, K. W. GAREY, R. A. ROBBINS, L. H. DANZIGER, and I. RUBINSTEIN Collection and Analysis of Exhaled Breath Condensate in Humans Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 731 - 737. [Full Text] [PDF]

				B. Balint, S.A. Kharitonov, T. Hanazawa, L.E. Donnelly, P.L. Shah, M.E. Hodson, and P.J. Barnes Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Eur. Respir. J., June 1, 2001; 17(6): 1201 - 1207. [Abstract] [Full Text] [PDF]